| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.01 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.01 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |